Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
  1. 4 Option exercise CHIEF MEDICAL OFFICER acquired 2,900 shares (option exercise)
  2. 4 Open-market buy 10% owner bought 100,000 shares at $11.60 ($1,160,000)
  3. 4 Option exercise CHIEF MEDICAL OFFICER acquired 13,100 shares (option exercise)
  4. 3/A Insider 3/A
  5. 4 Planned sale Director sold 25,000 shares at $12.57 ($314,250)
  6. 4 Open-market sale Director sold 8,181 shares at an average $14.39 ($117,740)
  7. 4 Open-market sale CHIEF MEDICAL OFFICER sold 14,556 shares at an average $14.38 ($209,296)
  8. 4 Open-market sale CH. DISCOV. & NON-CLIN DEV OFF sold 13,629 shares at an average $14.40 ($196,233)
  9. 4 Open-market sale PRESIDENT AND CEO sold 57,225 shares at an average $14.40 ($824,134)
  10. 4 Open-market sale CH. OPERATING & FINANCIAL OFF. sold 18,742 shares at an average $14.39 ($269,656)
  11. 4 Planned sale CH. DISCOV. & NON-CLIN DEV OFF sold 200 shares at $17.61 ($3,522)
  12. 4 Planned sale CH. DISCOV. & NON-CLIN DEV OFF sold 10,541 shares at an average $15.26 ($160,806)
  13. 4 Planned sale Director sold 30,000 shares at an average $12.65 ($379,450)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Planned sale Director sold 25,000 shares at $12.41 ($310,250)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Planned sale CH. DISCOV. & NON-CLIN DEV OFF sold 20,000 shares at $12.67 ($253,400)
  19. 4 Open-market buy Director bought 1,505,932 shares at $9.84 ($14,818,371)
  20. 4 Planned sale Director sold 25,000 shares at an average $10.26 ($256,600)

Page 6 of 13 · 244 filings